4//SEC Filing
MORPHIS GENE S 4
Accession 0001181431-03-033844
CIK 0000085417other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 11:36 AM ET
Size
11.3 KB
Accession
0001181431-03-033844
Insider Transaction Report
Form 4
MORPHIS GENE S
Chief Financial Officer
Transactions
- Award
Option to Purchase
2003-12-01$3.00/sh+12,000$36,000→ 35,000 totalExercise: $3.00From: 2003-12-01Exp: 2013-12-01→ common (12,000 underlying)
Holdings
- 5,334
Option to purchase
Exercise: $2.15From: 2004-06-03Exp: 2012-12-03→ common (1,333 underlying) - 18,000
Common Stock
- 8,000
Option to purchase
Exercise: $2.15From: 2005-06-03Exp: 2012-12-03→ common (1,333 underlying) - 13,000
Option to purchase
Exercise: $1.95From: 2002-07-30Exp: 2012-07-30→ common (5,000 underlying) - 18,000
Option to purchase
Exercise: $1.95From: 2003-07-30Exp: 2012-07-30→ common (5,000 underlying) - 23,000
Option to purchase
Exercise: $1.95From: 2004-07-30Exp: 2012-07-30→ common (5,000 underlying) - 1,334
Option to purchase
Exercise: $2.15From: 2002-12-03Exp: 2012-12-03→ common (1,334 underlying) - 2,668
Option to purchase
Exercise: $2.15From: 2002-06-03Exp: 2012-12-03→ common (1,334 underlying) - 4,001
Option to purchase
Exercise: $2.15From: 2003-12-03Exp: 2012-12-03→ common (1,333 underlying) - 6,667
Option to purchase
Exercise: $2.15From: 2005-12-03Exp: 2012-12-03→ common (1,333 underlying)
Issuer
ROWE COMPANIES
CIK 0000085417
Entity typeother
Related Parties
1- filerCIK 0001232811
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 11:36 AM ET
- Size
- 11.3 KB